Further Information
APP, amyloid beta (A4) precursor protein, AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN2, OTTHUMP00000096096, PN-II, alzheimer disease amyloid protein, amyloid beta A4 protein, beta-amyloid peptide, cerebral vascular amyloid peptide, peptidase nexin-II, preA4, protease nexin-II
Peptide ELISA: antibody detection limit dilution 1:8000.Western Blot:Approx 75kDa band observed in Human Brain (Cerebral and Frontal cortex) lysates (calculated MW of 78.7kDa according to NP_958817.1 and 72.6 according to NP_001129601.1). Recommended concentration: 1-3ug/ml. Primary incubation was 1 hour.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Expected Species Reactivity based on sequence homology: Dog, Pig, Cow
The immunogen for this antibody is: DAEFRHDSGYEVHHQK-C
351
amyloid beta (A4) precursor protein
APP
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
Approx 75 kDa
NP_000475.1, NP_958816.1, NP_958817.1, NP_001129601.1, NP_001129602.1
4502167
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
This antibody is expected to recognize all reported isoforms of APP (NP_000475.1; NP_958816.1; NP_958817.1; NP_001129601.1; NP_001129602.1) and to recognize all lengths of the Amyloid beta peptide.
P05067